Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201

PURPOSE: Platinum-based therapy is the standard of care in patients who have HER2-negative, advanced esophagogastric cancer (AEGC). Retrospective data suggest that intratumoral ERCC1 levels may determine platinum sensitivity. A randomized, phase II study was performed in patients with AEGC to explor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Iqbal, Syma, McDonough, Shannon, Lenz, Heinz-Josef, Ilson, David, Burtness, Barbara, Nangia, Chaitali S., Barzi, Afsaneh, Schneider, Charles J., Liu, Jane Jijun, Dotan, Efrat, Guthrie, Katherine A., Hochster, Howard S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007287/
https://ncbi.nlm.nih.gov/pubmed/31815582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00925
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados